Celebrating 30 years of SRNA. Together.
ENROLL TODAYThe first-ever online micro-course for people with ADEM, AFM, MOGAD, NMOSD, ON, and TM.LEARN MORE

SRNA

The nonprofit advocating for individuals with rare neuroimmune disorders

ADEM | AFM | MOGAD | NMOSD | ON | TM

Help us provide hope and help to those living with ADEM, AFM, MOGAD, NMOSD, ON, and TM.

No matter how much you choose to give, 100% will directly fund SRNA’s education, research, and community support programs.

International supporters: Please donate using this form

Hojas Informativas disponibles en Español

MFA
Mielitis Flácida Aguda

EMAD
Encefalomielitis Aguda Diseminada

MOGAD
Enfermedad de Anticuerpo MOG

NMOSD
Trastorno del Espectro Neuromielitis Óptica

NO
Neuritis Óptica

MT
Mielitis Transversa

Coronavirus (COVID-19) and Rare Neuroimmune Disorders

We know you have many questions about the coronavirus (COVID-19) and rare neuroimmune disorders, which is why we’ve worked with our medical experts to bring you the latest information on treatments, care, and support.

COVID-19 coronavirus and Rare Neuroimmune Disorders

We know you have many questions about COVID-19 coronavirus and rare neuroimmune disorders, which is why we’ve worked with our medical experts to bring you the latest information on treatments, care, and support.

COVID-19 coronavirus and Rare Neuroimmune Disorders

We know you have many questions about COVID-19 coronavirus and rare neuroimmune disorders, which is why we’ve worked with our medical experts to bring you the latest information on treatments, care, and support.

Our Hope Ambassadors

“Time is of the essence when it comes to rare neuroimmune disorders and the time to get awareness out is now. I know this because my 2 ½ year old son has Acute Flaccid Myelitis (AFM) which is a subtype of Transverse Myelitis.”

Read more about Elisa’s and Noah’s story. Elisa and Noah are one of SRNA’s Hope Ambassadors, a community of heroes for a common cause.

2024 Education Sponsors

All educational content and programs are solely developed by the SRNA staff, members of the scientific board and approved by Board of Directors.